Loading clinical trials...
Loading clinical trials...
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Radically Resected Non Small Cell Lung Cancer
Conditions
Interventions
Protein expression by immunohistochemistry and immunofluorescence
Locations
1
Italy
Istituto Clinco Humanitas
Rozzano, Milan, Italy
Start Date
November 1, 2007
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
September 10, 2022
NCT05671510
NCT03340506
NCT06066138
NCT07485114
NCT05098132
NCT04977453
Lead Sponsor
Armando Santoro, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions